NeuroOne stock is down on Q4 revenue misses
NeuroOne Medical Technologies (Nasdaq:NMTC) shares took a hit today on fourth-quarter results that fell shy of the consensus sales forecast.
Stay updated with breaking news from Massdevice Medtech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
NeuroOne Medical Technologies (Nasdaq:NMTC) shares took a hit today on fourth-quarter results that fell shy of the consensus sales forecast.
Edwards Lifesciences (NYSE:EW) announced today that it intends to spin off its critical care business by the end of 2024.
Medtronic reported Q2 that results beat The Street, with the medtech giant reporting strength across businesses and geographies.
Masimo has received FDA 510(k) clearance for its Masimo W1 medical watch for both over-the-counter and prescription use.
Alcon shares fell this morning on third-quarter results that came up shy of the consensus forecast.